Zhang, Quanjiang
Li, Zhonggang
Li, Qiuxia
Trammell, Samuel AJ https://orcid.org/0000-0002-5941-4094
Schmidt, Mark S https://orcid.org/0000-0003-4593-4096
Pires, Karla Maria https://orcid.org/0000-0002-5974-0279
Cai, Jinjin
Zhang, Yuan
Kenny, Helena
Boudina, Sihem https://orcid.org/0000-0002-4711-1109
Brenner, Charles https://orcid.org/0000-0002-4955-3226
Abel, E Dale https://orcid.org/0000-0001-5290-0738
Funding for this research was provided by:
HHS | National Institutes of Health (U54 HL112311)
HHS | National Institutes of Health (R01HL147545)
HHS | National Institutes of Health (R01HL149870-01A1)
HHS | National Institutes of Health (R01HL108379)
Alfred E. Mann Family Foundation (000000)
American Heart Association (20CDA35320042)
John B Stokes Chair in Diabetes Research from the Fraternal Order of Eagles Diabetes Research Center (000000)
Article History
Received: 20 January 2023
Revised: 31 October 2023
Accepted: 8 November 2023
First Online: 11 January 2024
Disclosure and competing interests statement
: CB is the chief scientific advisor of ChromaDex and co-founder of Alphina Therapeutics. The remaining authors declare no competing interests.